ASTRAZENECA COVID-19 VACCINE 79 PERCENT EFFECTIVE IN US TRIAL

Highlights

• AstraZeneca on Monday had published the first data from an interim safety and efficacy analysis of more than 30,000 volunteers

• AstraZeneca vaccine was 79 percent in a large US trial at preventing symptomatic illness, and was 100 percent effective against severe or critical disease and hospitalization

According to the data published by the UK based drug maker AstraZeneca, the COVID-19 vacci....